Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Preclinical and phase I data presented on Algipharma's OligoG

Oct. 15, 2010

Continuous exenatide delivery with ITCA-650 shows promise in phase II diabetes trial

Oct. 15, 2010

GAA peptide-loaded DC1-based vaccine shows promise in recurrent malignant glioma

Oct. 15, 2010

IPI-926 is well tolerated and active in patients with solid tumors

Oct. 15, 2010

Pritumumab is active in patients with brain cancer

Oct. 15, 2010

Studies further characterize HIV integrase inhibitor S/GSK-1349572

Oct. 14, 2010

Multiple studies describe preclinical profile of antibacterial polypeptide NZ-17074

Oct. 14, 2010

Piramal Life Sciences describes preclinical pharmacology of new insulin sensitizer P-1738

Oct. 14, 2010

PBT-434 prevents nigral cell death in models of Parkinson's disease

Oct. 14, 2010

Phase I/II trials suggest efficacy of Neuvax vaccine in prevention of breast cancer recurrence

Oct. 13, 2010

Popular Stories

Today's news in brief
BioWorld
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...